Loading viewer...
conference
Format: PDF conference
Regeneron Pharmaceuticals presented clinical and research advances in oncology and hematology at the 2023 American Society of Hematology conference. The presentation covered investigational bispecific antibodies including linvoseltamab for multiple myeloma and odronextamab for lymphomas, alongside classical hematology programs in complement inhibition, Factor XI antibodies, and genetic therapies.
investor_presentation
23 Pages
conference
21 Pages
Alignment Healthcare, Inc.
SS&C Technologies 2023 Needham Growth Conference Presentation
conferenceconference
18 Pages
SS&C Technologies Holdings, Inc.
MD Anderson Targeted Therapy Immunotherapy 2024
conferenceconference
28 Pages
MD Anderson Cancer Center
Newtek Business Services 2016 LD Micro Conference Presentation
conferenceconference
35 Pages
Newtek Business Services Corporation